EcoDrugPlus

Ribosomal Protein L37a

Ensembl ID : ENSFHEG00000018673
Gene Symbol: RPL37A
3 Cross references
455 Possible Orthologues:

Ribosomal Protein L38

Ensembl ID : ENSFHEG00000008898
Gene Symbol: RPL38
3 Cross references
247 Possible Orthologues:

Ribosomal Protein L39

Ensembl ID : ENSFHEG00000017908
Gene Symbol: RPL39
3 Cross references
282 Possible Orthologues:

Ribosomal Protein L4

Ensembl ID : ENSFHEG00000005347
Gene Symbol: RPL4
3 Cross references
340 Possible Orthologues:

Ribosomal Protein L5

Ensembl ID : ENSFHEG00000000576
Gene Symbol: RPL5
4 Cross references
457 Possible Orthologues:

Ribosomal Protein L5

Ensembl ID : ENSFHEG00000014391
Gene Symbol: RPL5
4 Cross references
452 Possible Orthologues:

Ribosomal Protein L6

Ensembl ID : ENSFHEG00000008998
Gene Symbol: RPL6
3 Cross references
487 Possible Orthologues:

Ribosomal Protein L7

Ensembl ID : ENSFHEG00000018324
Gene Symbol: RPL7
3 Cross references
492 Possible Orthologues:

Ribosomal Protein L7a

Ensembl ID : ENSFHEG00000002248
Gene Symbol: RPL7A
4 Cross references
372 Possible Orthologues:

Ribosomal Protein L8

Ensembl ID : ENSFHEG00000009770
Gene Symbol: RPL8
3 Cross references
278 Possible Orthologues:

Ribosomal Protein L9

Ensembl ID : ENSFHEG00000008785
Gene Symbol: RPL9
3 Cross references
505 Possible Orthologues:

Ribosomal Protein S10

Ensembl ID : ENSFHEG00000016772
Gene Symbol: RPS10
3 Cross references
384 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).